HIV-Positive Patients with Lung Cancer: Is Immunotherapy a Safe and Active Option for Them?

J Thorac Oncol. 2018 Jul;13(7):874-876. doi: 10.1016/j.jtho.2018.05.005.

Authors

Alejandro Navarro¹, Alex Martinez-Marti¹, Enriqueta Felip²

Affiliations

¹ Medical Oncology Department, Vall d'Hebron Hospital, Barcelona, Spain; Medical Oncology Department, Vall d'Hebron Institute of Oncology, Barcelona, Spain.
² Medical Oncology Department, Vall d'Hebron Hospital, Barcelona, Spain; Medical Oncology Department, Vall d'Hebron Institute of Oncology, Barcelona, Spain. Electronic address: [email protected].

PMID: 29935842
DOI: 10.1016/j.jtho.2018.05.005

No abstract available

Publication types

Editorial
Kommentar

MeSH terms

Carcinoma, Non-Small-Cell Lung*
HIV
Humans
Immunotherapy
Lung Neoplasms*
Programmed Cell Death 1 Receptor

Substances

Programmed Cell Death 1 Receptor